Professor, Medicine - Oncology, Stanford University Medical Center
Hematology
Dr. Branimir I. Sikic, MD
|
|
Give Review
Branimir Sikic practices Hematology. He went to University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine He received 1 awards: "Fellow (FASCO)". Branimir Sikic is a published doctor as well. He has 42 publications published. The latest was: Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.
Publications
- Mechanisms of resistance to cabazitaxel.
- A Phase I Dose Escalation and Expansion Study of the AntiCancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors.
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian Cancers.
- Identification of ovarian Cancer driver genes by using module network integration of multi-omics data.
- Molecular pathways: regulation and therapeutic implications of multidrug resistance.
- A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal Cancer.
- NFKBIA deletion in glioblastomas.
- Expression and silencing of the microtubule-associated protein Tau in breast Cancer cells.
- Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group.
- Phase I trial of oblimersen (Genasense(R)) and gemcitabine in refractory and advanced Malignancies.
- A network model of a cooperative genetic landscape in brain Tumors.
- Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
- A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal Cancer.
- Genomics of childhood leukemias: the virtue of complexity.
- Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success?
- Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
- Integrated high-resolution genome-wide analysis of gene dosage and gene expression in human brain Tumors.
- Multidrug resistance and stem Cells in acute myeloid leukemia.
- Regional activation of chromosomal arm 7q with and without gene amplification in taxane-selected human ovarian Cancer cell lines.
- Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid Malignancies.
- Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas.
- Gene expression profiling differentiates germ cell tumors from other Cancers and defines subtype-specific signatures.
- Genetic and epigenetic modeling of the origins of multidrug-resistant Cells in a human sarcoma Cell line.
- Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas.
- A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients w...
- Activity of novel cytotoxic agents in lung Cancer: epothilones and topoisomerase I inhibitors.
- Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal Cancer.
- High-resolution genome-wide mapping of genetic alterations in human glial brain Tumors.
- Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA.
- Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes.
- CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human Cancer cells.
- Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome...
- A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced Ovarian...
- Phase I and pharmacokinetic study of BMS-188797, a new taxane analog, administered on a weekly schedule in patients with advanced Malignancies.
- Gene expression patterns in ovarian Carcinomas.
- Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant Cells.
- Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography.
- Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.
- Re: genetic analysis of the beta-tubulin gene, TUBB, in non-small-cell lung Cancer.
- Conservation of the class I beta-tubulin gene in human populations and lack of mutations in lung Cancers and paclitaxel-resistant ovarian Cancers.
- Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.
Schools
Rosalind Franklin University Of Medicine ScienceThe Chicago Medical School
Georgetown University Hospital
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anemia
- Bladder Cancer
- Breast Cancer
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Fellow (FASCO)
Education
-
Georgetown University Hospital -
University of Chicago Pritzker School of Medicine
Hospital
-
Menlo Park Surgical Hospital -
Stanford Health Care
Helpful Reviews
Similar Doctors
|
|
Dr. Anosheh Afghahi, MD |
|
|
Dr. Gregory Heestand, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David S. Leibowitz, MD |
|
|
Dr. Ravindra Majeti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary-Elizabeth M. Percival, MD |
|
|
Dr. Myron M. Turbow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor M. Villalobos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juliet M. Kral, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruno C. Medeiros, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah M. Smith, MD |